The estimated budget impact of adding cabergoline to the formulary for Cushing’s disease (CD) treatment within the Brazilian Public Health System would be about BRL $6 million. While cost savings cannot be expected, the budget impact of adding cabergoline would be lower than that of adding other treatment options. … Read More →
Daily Archives: October 14, 2024
All the contents of this site, except where otherwise noted, is licensed under a Creative Commons Attribution License.
The posts are of the authors responsibility and don't necessarily convey the opinions of the SciELO Program.
SciELO - Scientific Electronic Library Online
CAPES - CNPq - FAPESP - BIREME - FapUNIFESP
https://www.scielo.org
blog.scielo@scielo.org
Recent Comments